Skip to content
DefDex

Federal award

KBR WYLE SERVICES, LLC

0208

Contract

Obligated and Ceiling

Obligated (net)
$47,426,025.29
Ceiling (potential value, not spending)
$47,595,440.00
Current value
$47,595,440.00
Gross positive obligations
$49,625,693.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
Owner company
KBRBasis reviewed link: a dated, evidenced ownership link.
Reported parent
KBR, INC. · VJ3XVZC76HT9
Awarding agency
Department of Defense · sub-agency 9763 · office S0107A
Funding agency
Department of Defense · sub-agency 5700
Product or service (PSC)
AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS)
541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
PIID
0208
Parent vehicle (IDV PIID)
HC104705D4005
Award type code
C
Actions
19 · Sep 27, 2011 to Sep 2, 2020
Why it is listed
gross positive obligations of $100k or more (contracts); reviewed company, $10k or more

Open this award on USAspending →

Action History19

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 2, 2020FY20201BC−$11,245.84
Feb 21, 2019FY20191AC−$158,168.87
Feb 19, 2015FY201516C$781,150.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Nov 25, 2014FY201515C$450,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 9, 2014FY201414B$1,400,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 30, 2013FY201313C$202,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 16, 2013FY201312C$523,290.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jun 21, 2013FY201311C$1,485,147.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Mar 19, 2013FY201310C$1,546,227.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Feb 21, 2013FY20139C$8,329,275.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 5, 2012FY20128B$0.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Aug 22, 2012FY20127C−$913,032.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Mar 30, 2012FY20126M$0.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Mar 29, 2012FY20125C$11,916,584.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Feb 13, 2012FY20124M$5,461,767.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Dec 9, 2011FY20123B$0.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Nov 30, 2011FY20122C−$1,117,221.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 28, 2011FY20111C$913,032.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 27, 2011FY20110—$16,617,221.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.